High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey. Bruni C, Chung L, Hoffmann-Vold AM, et al.  Clinical and Experimental Rheumatology. 2022 Oct;40(10):1951-1955. DOI: 10.55563/clinexprheumatol/7ry6zz. PMID: 35819810.

Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Vanessa Smith, Ariane L. Herrick, Francesca Ingegnoli, Nemanja Damjanov, Rossella De Angelis, Christopher P. Denton, Oliver Distler, Karinna Espejo, Ivan Foeldvari, Tracy Frech, Boris Garro, Marwin Gutierrez, Genevieve Gyger, Eric Hachulla, Roger Hesselstrand, Annamaria Iagnocco, Cristiane Kayser, Karin Melsens, Ulf Müller-Ladner, Sabrina Paolino, Carmen Pizzorni, Mislav Radic, Valeria Riccieri, Marcus Snow, Wendy Stevens, Alberto Sulli, Jacob M. van Laar, Madelon C. Vonk, Amber Vanhaecke, Maurizio Cutolo. Autoimmunity Reviews, Volume 19, Issue 3, 2020, 102458, ISSN 1568-9972, https://doi.org/10.1016/j.autrev.2020.102458.

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group; Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group. Ann Rheum Dis. 2019 Jun;78(6):807-816. doi: 10.1136/annrheumdis-2018-214764. Epub 2019 Mar 30. Erratum in: Ann Rheum Dis. 2019 Aug;78(8):e88. PMID: 30928903.

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups. Baron M, Kahaleh B, Bernstein EJ, Chung L, Clements PJ, Denton C, Domsic RT, Ferdowsi N, Foeldvari I, Frech T, Gordon JK, Hudson M, Johnson SR, Khanna D, McMahan Z, Merkel PA, Narain S, Nikpour M, Pauling JD, Ross L, Valenzuela Vergara AM, Vacca A. J Scleroderma Relat Disord. 2019 Feb;4(1):17-27. doi: 10.1177/2397198318783926. Epub 2018 Jul 18. PMID: 30906878; PMCID: PMC6428445.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report. Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL. J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24. PMID: 30705970; PMCID: PMC6350902.

A multi-national qualitative research study exploring the patient experience of Raynaud’s phenomenon in systemic sclerosis: A Scleroderma Clinical Trials Consortium Vascular Working Group initiative. Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S. Arthritis Care & Research 2018 Sep;70(9):1373-1384

Evolving symptoms of Raynaud’s phenomenon in systemic sclerosis are associated with physician and patient-reported assessments of disease severity. Pauling JD, Reilly E, Smith T, Frech TM. Arthritis Care & Research 2018 (ePub ahead of print)

Patient perceptions of the Raynaud’s Condition Score diary provide insight into its performance in clinical trials of Raynaud's phenomenon. Pauling JD, Saketkoo LA & Domsic RT. Arthritis & Rheumatology 2018 Jun;70(6):973-974.

An interim report of the Scleroderma Clinical Trials Consortium working groups. Baron, M., Kahaleh, B., Bernstein, E. J., Chung, L., Clements, P. J., Denton, C… Vacca, A. Journal of Scleroderma and Related Disorders (2018). https://doi.org/10.1177/2397198318783926 

Exploring the patient experience of digital ulcers in systemic sclerosis. Hughes M & Pauling JD. Seminars in Arthritis & Rheumatism 2018 (ePub ahead of print) DOI: 0.1016/j.semarthrit.2018.08.001

Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, Distler O, Foeldvari I, Kuwana M, Matucci-Cerinic M, Mayes M, Medsger T Jr, Merkel PA, Pope JE, Seibold JR, Steen V, Stevens W, Denton CP. J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18. doi: 10.5301/jsrd.5000231. PMID: 28516167

Towards developing criteria for scleroderma renal crisis: A scoping review. Hoa S, Stern EP, Denton CP, Hudson M; Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group Investigators of the Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group. Autoimmun Rev. 2017 Apr;16(4):407-415. doi: 10.1016/j.autrev.2017.02.012. Review. PMID: 28212921

Measures of disease status in systemic sclerosis: A systematic review. Tay T, Ferdowsi N, Baron M, Stevens W, Hudson M, Proudman SM, Nikpour M; Damage Index Working Group of the Scleroderma Clinical Trials Consortium. Semin Arthritis Rheum. 2017 Feb;46(4):473-487. doi: 10.1016/j.semarthrit.2016.07.010. PMID: 27765344

Calcinosis is associated with digital ulcers and osteoporosis in patients with Systemic Sclerosis: A Scleroderma Clinical Trials Consortium Study. Valenzuela A, Baron M, the Canadian Scleroderma Research Group, Herrick A, Proudman S, Stevens W, the Australian Scleroderma Interest Group, Rodriguez-Reyna T, Vacca A, Medsger TA, Fiorentino D, Chung L. Semin Arthritis Rheum. 2016 Dec;46(3):344-349. [PMID: 27371996]

Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis. Chung L, Valenzuela A, Fiorentino D, Stevens K, Li S, Harris J, Hutchinson C, Assassi S, Beretta L, Lakshminarayanan S, Rodriguez-Reyna TS, Denton CP, Taillefer RG, Herrick AL, Baron M; Scleroderma Clinical Trials Consortium Calcinosis Working Group. Arthritis Care Res (Hoboken). 2015 Mar;67(3):425-30. doi: 10.1002/acr.22434. PMID: 25155948

Validation of a Novel Radiographic Scoring System for Calcinosis Affecting the Hands of Patients with Systemic Sclerosis. Chung L, Valenzuela A, Fiorentino D, Stevens K, Li S, Harris J, Hutchinson C, Assassi S, Beretta L, Lakshminarayanan S, Rodriguez-Reyna TS, Denton CP, Taillefer RG, Herrick AL, Baron M; on behalf of the Scleroderma Clinical Trials Consortium Calcinosis Working Group. Arthritis Care Res (Hoboken). 2014 Aug 22. [PMID: 25155948]

Cardiac arrhythmias and conduction defects in systemic sclerosis. Vacca A, Meune C, Gordon J, Chung L, Proudman S, Assassi S, Nikpour M, Rodriguez-Reyna TS, Khanna D, Lafyatis R, Matucci-Cerinic M, Distler O, Allanore Y; Scleroderma Clinical Trial Consortium Cardiac Subcommittee. Rheumatology (Oxford). 2014 Jul;53(7):1172-7.

Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis. Merkel PA, Silliman NP, Clements PJ, Denton CP, Furst DE, Mayes MD, Pope JE, Polisson RP, Streisand JB, Seibold JR; Scleroderma Clinical Trials Consortium. Arthritis Rheum. 2012 Oct;64(10):3420-9. doi: 10.1002/art.34427. PMID: 22328195

Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts. Walker KM, Pope J; participating members of the Scleroderma Clinical Trials Consortium (SCTC); Canadian Scleroderma Research Group (CSRG). Semin Arthritis Rheum. 2012 Aug;42(1):42-55. doi: 10.1016/j.semarthrit.2012.01.003. PMID: 22464314

Clinical trial design in scleroderma: where are we and where do we go next? Chung L, Denton CP, Distler O, Furst DE, Khanna D, Merkel PA; Scleroderma Clinical Trials Consortium. Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S97-102. PMID: 22691217

Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS). Pope J. Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S98-111. doi: 10.1002/acr.20598. Review. No abstract available. PMID: 22588774

Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis. Walker KM, Pope J; Scleroderma Clinical Trials Consortium; Canadian Scleroderma Research Group. J Rheumatol. 2011 Jul;38(7):1326-8. doi: 10.3899/jrheum.101262. PMID: 21459952

Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein GS, Kavanaugh AF, Weisman M, Mayes MD, Collier D, Csuka ME, Simms R, Merkel PA, Medsger TA Jr, Sanders ME, Maranian P, Seibold JR; Relaxin Investigators and the Scleroderma Clinical Trials Consortium. Arthritis Rheum. 2009 Apr;60(4):1102-11. doi: 10.1002/art.24380. PMID: 19333948

Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, Matucci-Cerinic M, Denton CP, Mayes MD, Steen VD, Varga J, Furst DE; Scleroderma Clinical Trials Consortium co-authors. Ann Rheum Dis. 2008 May;67(5):703-9.